GlassScriptPhysician profile
Christopher Allyn Stiff
NPI 1679550180
$1,297.09
in general payments reported to CMS, 2019-2025
24 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $645 · 2020: $244 · 2021: $14.90 · 2022: $36.73 · 2023: $69.06 · 2024: $169 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $355.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $162.65 | 2019-2020 | |
| Medtronic, INC. | $150.94 | 2022-2024 | Interstim |
| Dendreon Pharmaceuticals LLC | $144.95 | 2019-2023 | Provenge |
| Boston Scientific Corporation | $141.18 | 2019-2025 | General - Female Sui |
| Antares Pharma, INC. | $125.80 | 2019-2020 | |
| Pfizer INC. | $106.14 | 2019-2020 | |
| Tolmar, INC. | $63.29 | 2023-2025 | Eligard |
| Endo Pharmaceuticals INC. | $45.68 | 2019-2023 | Aveed, Xiaflex, Edex |
| Amgen INC. | $44.46 | 2019-2020 | |
| Tolmar Pharmaceuticals, INC. | $41.07 | 2019 | |
| Urogen Pharma, INC. | $29.72 | 2025 | |
| Blue Earth Diagnostics | $26.98 | 2019 | |
| Zyla Life Sciences, INC. | $26.80 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $22.66 | 2025 | Gemtesa |
| Ferring Pharmaceuticals INC. | $21.40 | 2025 | Adstiladrin |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $20.10 | 2019 | |
| Medline Industries LP | $17.51 | 2019 | |
| Medtronic USA, INC. | $17.46 | 2020 | |
| Merck Sharp & Dohme LLC | $16.45 | 2019 | |
| Olympus America INC. | $15.87 | 2020 | |
| Axonics, INC. | $14.91 | 2022 | |
| Innocoll Pharmaceuticals Limited | $14.90 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.53 | 2019 | |
| Dentsply Ih INC. | $11.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Stiff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.